glp-1 agonists names America's Poison Centers GLP-1 Receptor Agonists: Mascots &

This activity of GLP-1 has been demonstrated in both preclinical and clinical studies, and the results support the hypothesis that the GLP-1 pathway regulates the processes of alcohol use disorder (AUD)

While branded agents like Ozempic, Jardiance, and Farxiga are highly effective, their cost may pose barriers

Moreover, the observation that adding GLP-1MK-801 treatment on top of semaglutide leads to an additional weight loss of 7% in mice that have reached a weight loss plateau with semaglutide provides additional support for integrating NMDA receptor antagonism in next-generation weight loss therapeutics

Lowering the dose of GLP-1 receptor agonist or using a slower titration regimen may help to mitigate these effects

Food and Drug Administration approved a GLP-1 drug, Wegovy, for use by adults with obesity or a weight-related condition